Investment State-of-Play in Big Pharma: Bayer’s Eugene Borukhovich Weighs In
Bayer’s G4A team has just launched their 2019 program. Are you a startup interested in applying? A health tech innovator wondering what a big pharma co…
Bayer’s G4A team has just launched their 2019 program. Are you a startup interested in applying? A health tech innovator wondering what a big pharma co…
A new ecosystem of health innovation to prevent disease, nurtures health, encourages a culture of wellness and generates value for business Milan, 1 A…
An article by Dominic Tyer, Creative Director at pharmaphorum Connect Eleven years is a long time to be writing about ‘digital pharma’, and I do indee…
HealthTech prominently featured in Comatose, a globe-trotting fiction novel crafted on lucid dreams from Tony Estrella and published by Cranthorpe Mill…
The case for increasing representation in digital health investing When it comes to digital health, investors get a bird’s eye view and play a major r…
An interview by Richard Staines, journalist at pharmaphorum, with Jeanne Barnett, founder of the website CysticFibrosis.com and blockchain advocate, ab…
Pharma companies, the health industry’s original lovers of all things innovation, have embraced digital health with abandon over the past four years. A…
Transforming people is not for faint-hearted managers One of the biggest challenges in transforming a company is to keep a workforce up to date with t…
You have to get out of the "man vs. machines" logic to embrace the "man and machines" logic More and more often and with an increased emphasis we thin…
At CES 2019, the digital therapeutic company's CEO and cofounder described work on an independent prescription, procurement and support platform specif…